Share

Latest Documents


  • 1-March-2021

    English

    Building and sustaining collaborative platforms in genomics and biobanks for health innovation

    Genomic and biobank collaborative platforms hold significant promise for the development of new discoveries and therapies. This paper explores the complex technical, legal and business challenges arising from genomics and biobanks, and brings together ideas and best practices from major national and international platforms, and from a diverse range of experts. The global sharing of biological samples and genomic data has been critical for accelerating our understanding of the biology and spread of COVID-19, and for the development of vaccines and diagnostics. Although some of the policy challenges in the field are well known, they have been reconfigured by the digitalisation of health innovation combined with the increasing complexity and volume of data, the push for global collaboration, and the growing awareness of ethical, legal, and social implications.
  • 25-February-2021

    English

    Neurotechnology in and for society: Deliberation, stewardship and trust

    This workshop on 19-20 May 2021 will focus on enabling societal deliberation on neurotechnology and promoting cultures of stewardship and trust in neurotechnology across the public and private sector in the context of the OECD Recommendation on Responsible Innovation in Nanotechnology.

    Related Documents
  • 3-November-2020

    English

    Key nanotechnology indicators

    Indicators include nanotech firms, nanotech R&D, public sector R&D expenditure and nanotechnology patents.

    Related Documents
  • 3-November-2020

    English

    Key biotechnology indicators

    Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.

  • 11-December-2019

    English

    OECD Recommendation on Responsible Innovation in Neurotechnology

    This Recommendation aims to provide guidance for governments and innovators to anticipate and address the ethical, legal and social challenges raised by novel neurotechnologies while promoting innovation in the field.

    Related Documents
  • 17-October-2019

    English

    Policy initiatives for health and the bioeconomy

    This document presents and compares 12 policy initiatives from OECD countries with a focus on policy objectives, target groups, sectoral priorities, budget, time horizon, selection criteria, international collaboration, and evaluation of the initiatives.

    Related Documents
  • 11-October-2019

    English

    Responsible innovation in neurotechnology enterprises

    Novel neurotechnology offers significant potential but raises a range of unique ethical, legal, and policy questions that business models will have to address. This paper is the result of analytical work on the opportunities and challenges of implementing responsibility frameworks into neurotechnology translation at major brain research initiatives and in the private sector.

    Related Documents
  • 5-September-2019

    English

    Innovation ecosystems in the bioeconomy

    Building on qualitative case studies and interviews, this study reveals the diverse ways countries are seeking to achieve goals set by national bioeconomy strategies and policies. It generates both common and country-specific insights that can enable the transition from a fossil-based economy to a more sustainable one.

    Related Documents
  • 27-November-2018

    English

    Realising the circular bioeconomy

    The bioeconomy, and then the circular economy, have gained political traction over the past decade. While there are synergies to be exploited, there are also potential misalignments. This paper attempts to highlight policy issues that will confront countries.

    Related Documents
  • 7-September-2018

    English

    Workshop on Minding Neurotechnology: Delivering responsible innovation for health and well-being

    This workshop, held in Shanghai on 6-7 September 2018, focused on exploring some of the unique ethical, legal and policy challenges raised by health-related applications of brain science and its integration into cutting-edge neurotechnologies. A key aim was to provide a forum for innovators to discuss strategies for delivering responsible innovation in neurotechnology for health and well-being applications.

    Related Documents
  • 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>